Metformin for obesity and glucose dysregulation in patients with schizophrenia receiving antipsychotic drugs

Metabolic Risk Factors Among Medicaid Outpatients With Schizophrenia Receiving Second-Generation Antipsychotics

(2014) Ryan C. Bell et al.   PSYCHIATRIC SERVICES

Efficacy of Metformin and Topiramate in Prevention and Treatment of Second-Generation Antipsychotic–Induced Weight Gain

(2010) Lara K Ellinger et al.   ANNALS OF PHARMACOTHERAPY

Patterns of Antipsychotic Medication Use in Australia 2002–2007

(2010) Samantha A. Hollingworth et al.   AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY

Metformin for Atypical Antipsychotic-Induced Weight Gain and Glucose Metabolism Dysregulation

(2010) Mehrul Hasnain et al.   CNS DRUGS

The Effect of Metformin on Anthropometrics and Insulin Resistance in Patients Receiving Atypical Antipsychotic Agents

(2010) Megan Ehret et al.   JOURNAL OF CLINICAL PSYCHIATRY

Effectiveness of Medications Used to Attenuate Antipsychotic-Related Weight Gain and Metabolic Abnormalities: A Systematic Review and Meta-Analysis

(2010) Lawrence Maayan et al.   NEUROPSYCHOPHARMACOLOGY

Clinical and economic ramifications of switching antipsychotics in the treatment of schizophrenia

(2009) Douglas E Faries et al.   BMC Psychiatry

Antipsychotic-Induced Weight Gain in Chronic and First-Episode Psychotic Disorders

(2009) Mario Álvarez-Jiménez et al.   CNS DRUGS

Regression From Pre-Diabetes to Normal Glucose Regulation in the Diabetes Prevention Program

(2009) L. Perreault et al.   DIABETES CARE

Prevalence and awareness of cardiovascular risk factors in patients with schizophrenia: A cross-sectional study in a low cardiovascular disease risk geographical area

(2009) M. Bernardo et al.   EUROPEAN PSYCHIATRY

Changes in weight and metabolic parameters during treatment with antipsychotics and metformin: do the data inform as to potential guideline development? A systematic review of clinical studies

(2009) C. J. Bushe et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Metformin for Weight Control in Pediatric Patients on Atypical Antipsychotic Medication

(2009) Lauren Shin et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study

(2009)   LANCET

Management of Atypical Antipsychotic Drug–Induced Weight Gain: Focus on Metformin

(2009) Lisa J Miller   PHARMACOTHERAPY

Extended release metformin for metabolic control assistance during prolonged clozapine administration: A 14 week, double-blind, parallel group, placebo-controlled study

(2009) Edgardo Carrizo et al.   SCHIZOPHRENIA RESEARCH

Metformin Addition Attenuates Olanzapine-Induced Weight Gain in Drug-Naive First-Episode Schizophrenia Patients: A Double-Blind, Placebo-Controlled Study

(2008) Ren-Rong Wu et al.   AMERICAN JOURNAL OF PSYCHIATRY

Lifestyle Intervention and Metformin for Treatment of Antipsychotic-Induced Weight Gain

(2008) Ren-Rong Wu et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Weight Loss of Black, White, and Hispanic Men and Women in the Diabetes Prevention Program

(2008) Delia S. West et al.   Obesity

Metformin plus sibutramine for olanzapine-associated weight gain and metabolic dysfunction in schizophrenia: A 12-week double-blind, placebo-controlled pilot study

(2008) Trino Baptista et al.   PSYCHIATRY RESEARCH

Metformin for metabolic dysregulation in schizophrenic patients treated with olanzapine

(2007) Chun-Hsin Chen et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY